Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
<p>HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can pre...
Main Authors: | Ahmed, T, Tina Ahmed |
---|---|
Outros Autores: | Hanke, T |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
2014
|
Assuntos: |
Registos relacionados
-
The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
Por: Wan, L, et al.
Publicado em: (2012) -
Architecture of the HIV-1 glycan shield
Por: Pritchard, L
Publicado em: (2014) -
HIV-specific interleukin-10 responses and immune modulation
Por: Clutton, G
Publicado em: (2012) -
Antibody-based HIV-1 vaccines: recent developments and future directions
Por: Montefiori, D, et al.
Publicado em: (2007) -
T-cell receptor (TCR) usage in HIV-2 infection
Por: Moysi, E
Publicado em: (2012)